Lee H, Lee YH, Kim SU, Kim HC (2021) Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol 19:2138–2147.e2110
Lin H, Zhang X, Li G, Wong GL, Wong VW (2021) Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J Clin Transl Hepatol 9:972–982
PubMed PubMed Central Google Scholar
Lim S, Kim JW, Targher G (2021) Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab 32:500–514
Article CAS PubMed Google Scholar
Tanase DM, Gosav EM, Costea CF et al (2020) The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res 2020:3920196
Article PubMed PubMed Central Google Scholar
Targher G, Byrne CD, Tilg H (2020) NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69:1691–1705
Article CAS PubMed Google Scholar
Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF (2022) Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut 71:1867–1875
Abdelmalek MF (2021) Nonalcoholic fatty liver disease: another leap forward. Nat Rev Gastroenterol Hepatol 18:85–86
Article PubMed PubMed Central Google Scholar
Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023
Stefan N, Häring H-U, Cusi K (2019) Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol 7:313–324
Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1264–1281 e1264
Makri E, Goulas A, Polyzos SA (2021) Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res 52:25–37
Article CAS PubMed Google Scholar
Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397:2212–2224
Article CAS PubMed Google Scholar
Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S (2018) Noninvasive biomarkers in NAFLD and NASH—current progress and future promise. Nat Rev Gastroenterol Hepatol 15:461–478
Article CAS PubMed Google Scholar
Zhang YN, Fowler KJ, Hamilton G et al (2018) Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol 91:20170959
Article PubMed PubMed Central Google Scholar
Artz NS, Hines CD, Brunner ST et al (2012) Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol 47:603–610
Article PubMed PubMed Central Google Scholar
Beck S, Jahn L, Deniffel D et al (2022) Iodine images in dual-energy CT: detection of hepatic steatosis by quantitative iodine concentration values. J Digit Imaging 35:1738–1747
Article PubMed PubMed Central Google Scholar
Rogier J, Roullet S, Cornelis F et al (2015) Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl 21:690–695
Pickhardt PJ, Hahn L, Munoz del Rio A, Park SH, Reeder SB, Said A (2014) Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. AJR Am J Roentgenol 202:752–758
Bae JC, Lee WY, Yoon KH et al (2015) Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial. Diabetes Care 38:1245–1252
Article CAS PubMed Google Scholar
Zhao XM, Wang M, Wu RZ et al (2018) Dual-layer spectral detector CT monoenergetic reconstruction improves image quality of non-contrast cerebral CT as compared with conventional single energy CT. Eur J Radiol 103:131–138
Bai X, Gao P, Zhang D et al (2020) Plaque burden assessment and attenuation measurement of carotid atherosclerotic plaque using virtual monoenergetic images in comparison to conventional polyenergetic images from dual-layer spectral detector CT. Eur J Radiol 132:109302
Albrecht MH, De Cecco CN, Schoepf UJ et al (2018) Dual-energy CT of the heart current and future status. Eur J Radiol 105:110–118
Zeng Y-R, Yang Q-H, Liu Q-Y et al (2019) Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma. World J Gastroenterol 25:1986–1996
Article CAS PubMed PubMed Central Google Scholar
Rassouli N, Etesami M, Dhanantwari A, Rajiah P (2017) Detector-based spectral CT with a novel dual-layer technology: principles and applications. Insights Imaging 8:589–598
Article PubMed PubMed Central Google Scholar
Zheng X, Ren Y, Phillips WT et al (2013) Assessment of hepatic fatty infiltration using spectral computed tomography imaging: a pilot study. J Comput Assist Tomogr 37:134–141
Molwitz I, Campbell GM, Yamamura J et al (2022) Fat quantification in dual-layer detector spectral computed tomography: experimental development and first in-patient validation. Invest Radiol 57:463–469
Article CAS PubMed PubMed Central Google Scholar
Bossuyt, Reitsma PM, Bruns DE JB et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527
Article PubMed PubMed Central Google Scholar
Guo Z, Blake GM, Li K et al (2020) Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction: a prospective study of 400 healthy volunteers. Radiology 294:89–97
Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging–estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425
Huang X, Gao S, Ma Y, Lu X, Jia Z, Hou Y (2020) The optimal monoenergetic spectral image level of coronary computed tomography (CT) angiography on a dual-layer spectral detector CT with half-dose contrast media. Quant Imaging Med Surg 10:592–603
Article PubMed PubMed Central Google Scholar
Jia Y, Xiao X, Sun Q, Jiang H (2018) CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology. Clin Radiol 73:1033–1040
Article CAS PubMed Google Scholar
Deniffel D, Sauter A, Fingerle A, Rummeny EJ, Makowski MR, Pfeiffer D (2021) Improved differentiation between primary lung cancer and pulmonary metastasis by combining dual-energy CT-derived biomarkers with conventional CT attenuation. Eur Radiol 31:1002–1010
留言 (0)